Beranda › Neuropati Sensorik dan Otonom Herediter › Tennessee › Nashville
Uji klinis Neuropati Sensorik dan Otonom Herediter di Nashville, TN
6 studi untuk Neuropati Sensorik dan Otonom Herediter mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of ACR-2316 in Specific Advanced Solid Tumors
Menerima pesertaFase 1/2
- Tennessee Oncology, Franklin · 17 mi jauhnya
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Sarah Cannon Research Institute, Nashville
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Menerima pesertaFase 1/2
- SCRI Oncology Partners, Nashville
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Menerima pesertaFase 1
- Sarah Cannon Cancer Center, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Menerima pesertaStudi observasional
- Sarah Cannon Research Institute, Nashville
Uji klinis Neuropati Sensorik dan Otonom Herediter di kota lain
- Arlington, VA7 studi
- San Antonio, TX7 studi
- New York City, NY6 studi
- Boston, MA6 studi
- Houston, TX5 studi
- Philadelphia, PA5 studi
- Portland, OR4 studi
- Pittsburgh, PA4 studi
- Ann Arbor, MI4 studi
- Washington, DC4 studi
- Aurora, CO3 studi
- Los Angeles, CA3 studi
Studi lain di Nashville
- Kanker Paru Non-Sel Kecil97 studi
- Kanker Payudara81 studi
- Kanker Metastatik70 studi
- Kanker Kolorektal69 studi
- Kanker (semua jenis)65 studi
- Kanker Ovarium49 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Karsinoma Sel Skuamosa Kepala dan Leher39 studi
- Kanker Pankreas39 studi
- Kanker Endometrium38 studi
- Melanoma33 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.